New Treatment For Advanced High-Grade Neuroendocrine Gastroenteropancreatic Tumors

Precision Oncology specialist, Alex Rolland, discusses a new leading-edge FDA-approved treatment that is a game-changer for patients with advanced high-grade gastroenteropancreatic neuroendocrine tumors. He explains the results of the recent NETTER-2 Study and the key takeaways that impact patients with this amazing new first-line treatment. He is joined by Precision Oncology Advocate and CTOAM cofounder, Michelle Morand. They share the key takeaways that all cancer patients need to know about this new treatment – including next steps you can take to find out if it will work for you and how to access it. 00:00 Introduction 00:16 Alex’s Presentation: Advanced New Treatment For: Advanced High-Grade Gastroenteropancreatic Neuroendocrine Tumors 2:26 What are gastroenteropancreatic neuroendocrine tumors? 3:58 Why these tumors are often difficult to treat 4:50 What are somatostatin receptors (SSTR) 6:31 Differences between SSTR1, 2, 3, 4, and 5 8:01 What is the new FDA-approved drug for this? 9:54 How this new treatment works 11:06 The importance of the recent NETTER-2 Study 14:08 Exploring the results of the NETTER-2 Study 16:10 Next steps patients can take to find out if this treatment can help them Read more about the NETTER-2 Study: https://ascopubs.org/doi/10.1200/JCO.... If you’d like to identify the most effective treatment for your cancer, and how to access it as soon as possible (and through your current treatment team, for as little cost as possible), reach out to us and book a free 30-min consult using the link below 👇 Book a Free Session With Alex And His Precision Oncology Team: https://www.ctoam.com/free-strategy-s... Download CTOAM’S Free Ebook Here: https://www.ctoam.com/ebook/ - CTOAM is a worldwide, Canadian-based personalized cancer care and precision oncology service specializing in getting our client's rapid access to the best possible cancer treatment available for their form of cancer, while assisting their physicians in having the most current data from which to make confident treatment decisions on your behalf. We facilitate access to peer-reviewed, science-based precision diagnostics such as PET/CT scans, liquid biopsy (blood-based genetic tests) and detailed genetic panels. We use these leading diagnostic tools, combined with a thorough and personalized research review, as our team explores the most advanced scientific data available today to find the best options for you. Other ways to stay in touch with CTOAM: Facebook:   / cancertreatmentoptionsandmanagement   LinkedIn:   / ctoam   Twitter:   / ctoam   Blog: https://research.ctoam.com/ LinkedIn (Liquid Biopsy Labs):   / 13063544   LBL Twitter:   / liquidbiopsynow   Disclaimer: Please understand that these videos are meant for educational purposes only. These videos are not intended to diagnose or be used as treatment advice. Viewers are encouraged to speak with their doctor or healthcare professionals for medical advice and before making any changes to their healthcare based on this information. All statements made in this video regarding medical treatments and health conditions are sourced and have been approved by the U.S. Food and Drug Administration (FDA). Watching this video is not a substitute for professional medical advice or a diagnosis.